Johnson & Johnson's Revenue by Segment
In fiscal year 2025, Johnson & Johnson's revenue by segment (products & services) are as follows:
- Innovative Medicine: $60.40 B
- MedTech: $33.79 B
Learn more about Johnson & Johnson’s Revenue by Geography
Check out competitors to Johnson & Johnson in a side-by-side comparison.
Explore additional financial metrics for Johnson & Johnson.
Johnson & Johnson's Revenue Share by Segment
| Innovative Medicine | 54759000000 |
|---|---|
| MedTech | 30400000000 |
| Innovative Medicine | 56964000000 |
|---|---|
| MedTech | 31857000000 |
| Innovative Medicine | 60401000000 |
|---|---|
| MedTech | 33792000000 |
The above chart shows Johnson & Johnson's revenue percentage share by segment (products and services).
In fiscal year 2023, Johnson & Johnson's revenue by segment is as follows:
- Innovative Medicine generated $54.76 B in revenue, representing 64.3% of its total revenue.
- MedTech generated $30.40 B in revenue, representing 35.7% of its total revenue.
The biggest segment for Johnson & Johnson is the Innovative Medicine, which represents 64.3% of its total revenue.
The smallest segment for Johnson & Johnson is the MedTech, which represents 35.7% of its total revenue.
The above chart shows Johnson & Johnson's revenue percentage share by segment (products and services).
In fiscal year 2024, Johnson & Johnson's revenue by segment is as follows:
- Innovative Medicine generated $56.96 B in revenue, representing 64.13% of its total revenue.
- MedTech generated $31.86 B in revenue, representing 35.87% of its total revenue.
The biggest segment for Johnson & Johnson is the Innovative Medicine, which represents 64.13% of its total revenue.
The smallest segment for Johnson & Johnson is the MedTech, which represents 35.87% of its total revenue.
The above chart shows Johnson & Johnson's revenue percentage share by segment (products and services).
In fiscal year 2025, Johnson & Johnson's revenue by segment is as follows:
- Innovative Medicine generated $60.40 B in revenue, representing 64.12% of its total revenue.
- MedTech generated $33.79 B in revenue, representing 35.88% of its total revenue.
The biggest segment for Johnson & Johnson is the Innovative Medicine, which represents 64.12% of its total revenue.
The smallest segment for Johnson & Johnson is the MedTech, which represents 35.88% of its total revenue.
Summary Table
| Products & Services (Percent Share) | 2023 | 2024 | 2025 |
|---|---|---|---|
| Innovative Medicine | 64.3% | 64.13% | 64.12% |
| MedTech | 35.7% | 35.87% | 35.88% |
| Total Revenue | 100% | 100% | 100% |
Johnson & Johnson's Segments Revenue Trend
The above chart shows the revenue trend of different segments of Johnson & Johnson.
In fiscal year 2025, the Innovative Medicine generated the most revenue ($60.40 B), and the MedTech generated the least revenue ($33.79 B).
Johnson & Johnson's Revenue Growth Drivers
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.





